ACADIA Pharmaceuticals to Present at the 8th Annual JMP Securities Healthcare Conference on July 9, 2013 ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the 8th Annual JMP Securities Healthcare Conference on Tuesday, July 9, 2013, at 1:00 p.m.
July 2, 2013 - Business Wire via Yahoo! Finance
ACADIA Pharmaceuticals Added to Russell 2000 Index ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has been added to the Russell 2000 Index effective after the close of market on Friday, June 28, 2013, as part of Russell Investments’ annual index reconstitution.
July 1, 2013 - Business Wire via Yahoo! Finance